logo
Geographic variations of acute heart failure syndromes: The importance of clinical registries
Phase II trials in heart failure: The role of cardiovascular imaging
Ischemic heart disease: Comprehensive evaluation by cardiovascular magnetic resonance
Differential impact of race and risk factors on incidence of atrial fibrillation
Diagnosis and management issues in thoracic aortic aneurysm
A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: Rationale and design of the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction trial
The ω-3 fatty acids for Prevention of Post-Operative Atrial Fibrillation trial—rationale and design
Troponin measurements during drug development—considerations for monitoring and management of potential cardiotoxicity
Prevalence and correlates of smoking cessation pharmacotherapy in hospitalized smokers with acute myocardial infarction
Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome
Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: Observations from “Assessment of Pexelizumab in Acute Myocardial Infarction”
Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial
Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: A meta-analysis of randomized trials
Practice variability and outcomes of coil embolization of aortopulmonary collaterals before fontan completion: A report from the Pediatric Heart Network Fontan Cross-Sectional Study
Growth differentiation factor 15: An additional diagnostic tool for the risk stratification of developing heart failure in patients with operated congenital heart defects?
Resting cardiac energy metabolism is inversely associated with heart rate in healthy young adult men
The Romanian Acute Heart Failure Syndromes (RO-AHFS) Registry
Atrial fibrillation and mortality in African American patients with heart failure: Results from the African American Heart Failure Trial (A-HeFT)
The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: Combined analysis of the ONSET/OFFSET and RESPOND studies
Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin use
Changes in reference vessel diameter in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention: Implications for appropriate stent sizing
Association of initial Thrombolysis in Myocardial Infarction flow grade with mortality among patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A National Registry of Myocardial Infarction-5 (NRMI-5) analysis
Body mass index and health status in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial (BARI 2D)
Long-term results of atrial fibrillation ablation: The importance of all initial ablation failures undergoing a repeat ablation
Optimizing electrocardiographic interpretation in acute ST-elevation myocardial infarction may be very beneficial
Appropriate cardiac catheterization laboratory activation: Optimizing electrocardiogram interpretation and clinical decision making for acute ST-elevation myocardial infarction
Appropriate cardiac catheterization laboratory activation: Author reply
Acute hyperglycemia: Is really a new risk marker for contrast-induced nephropathy in patients with acute myocardial infarction without diabetes and normal renal function?
Author's reply to Acute hyperglycemia: Is really a new risk marker for contrast-induced nephropathy in patients with acute myocardial infarction without diabetes and normal renal function?
Regarding “The EVEREST II Trial: Design and rationale for a randomized study of the Evalve MitraClip system compared with mitral valve surgery for mitral regurgitation”
In response to the letter to the editor of Cikirikcioglu et al regarding “The EVEREST II Trial: Design and rationale for a randomized study of the Evalve MitraClip system compared with mitral valve surgery for mitral regurgitation”
Liver transaminase levels alone could not be the optimal method to estimate hepatic safety after statin administration in patients with chronic kidney disease
Standard versus high loading doses of clopidogrel in Asian patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Insights from the Korea Acute Myocardial Infarction Registry
Do East Asians have different hypercoagulable states compared with Western population?
Response to the letter regarding the article “Do East Asians have different hypercoagulable states compared with Western population?”